These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1387399)

  • 21. The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7.
    Preissner KT; Podack ER; Müller-Eberhard HJ
    J Immunol; 1985 Jul; 135(1):445-51. PubMed ID: 3998468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular architecture of human complement component C6.
    DiScipio RG; Hugli TE
    J Biol Chem; 1989 Sep; 264(27):16197-206. PubMed ID: 2789218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins.
    Podack ER; Biesecker G; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):897-901. PubMed ID: 284414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway.
    Krisinger MJ; Goebeler V; Lu Z; Meixner SC; Myles T; Pryzdial EL; Conway EM
    Blood; 2012 Aug; 120(8):1717-25. PubMed ID: 22802338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Freeze-thaw activation of the complement attack phase: I. Separation of two steps in the formation of the active C--56 complex.
    Dessauer A; Rother U; Rother K
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():75-81. PubMed ID: 6587745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.
    Hammer CH; Nicholson A; Mayer MM
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5076-80. PubMed ID: 1061092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.
    Sturtevant JE; Balber AE
    Exp Parasitol; 1987 Jun; 63(3):260-71. PubMed ID: 3556206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of human beta-endorphin with the terminal SC5b-9 and "preterminal" SC5b-7 and SC5b-8 complexes of human complement.
    Schweigerer L; Teschemacher H; Bhakdi S
    Life Sci; 1982 Nov 15-22; 31(20-21):2275-8. PubMed ID: 6186881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SC5b-7 complex: formation, isolation, properties, and subunit composition.
    Podack ER; Kolb WP; Müller-Eberhard HJ
    J Immunol; 1977 Dec; 119(6):2024-9. PubMed ID: 410885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative inefficiency of terminal complement activation.
    Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
    J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The release of C5a in complement-activated serum does not require C6.
    Biesecker G; Wagner JL; Hugli TE
    J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The complex of C5b and C6: isolation, characterization, and identification of a modified form of C5b consisting of three polypeptide chains.
    Yamamoto KI; Gewurz G
    J Immunol; 1978 Jun; 120(6):2008-15. PubMed ID: 659890
    [No Abstract]   [Full Text] [Related]  

  • 35. Structure, function and control of complement C5 and its proteolytic fragments.
    Laursen NS; Magnani F; Gottfredsen RH; Petersen SV; Andersen GR
    Curr Mol Med; 2012 Sep; 12(8):1083-97. PubMed ID: 22812419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional insights from the structure of the multifunctional C345C domain of C5 of complement.
    Bramham J; Thai CT; Soares DC; Uhrín D; Ogata RT; Barlow PN
    J Biol Chem; 2005 Mar; 280(11):10636-45. PubMed ID: 15598652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of C5b-6 suggests structural basis for priming assembly of the membrane attack complex.
    Aleshin AE; DiScipio RG; Stec B; Liddington RC
    J Biol Chem; 2012 Jun; 287(23):19642-52. PubMed ID: 22500023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidants generated by the myeloperoxidase-halide system activate the fifth component of human complement, C5.
    Vogt W; Hesse D
    Immunobiology; 1994 Dec; 192(1-2):1-9. PubMed ID: 7750983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
    J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.